Recent scientific advances have dramatically changed the outlook for people with cystic fibrosis (CF). The introduction of CFTR modulators—medications that target the root cause of the disease rather than just its symptoms—has transformed patient lives, improving lung function, stamina, and overall quality of life. These treatments are lifelong and represent a major breakthrough in CF care.
Accessibility and Ongoing Research
Not all patients can yet benefit from the new therapies, as genetic mutations vary from person to person. Research continues into new drugs and gene therapy, which aims to correct the underlying genetic defect. Experts predict that gene-based approaches could become widely available within the next decade, potentially offering a cure rather than just management of symptoms.
Advanced Disease and Lung Transplants
For patients who reach advanced stages of respiratory failure, lung transplantation remains the only viable option. Although donor organs are limited, the development of a national transplant program in Greece is already providing hope and saving lives.
Remembering Anastasia Tasoula
The CF community was deeply moved by the story of Anastasia Tasoula, a 27-year-old patient who became internationally known as the first person to wake after 221 days in a medically induced coma. Anastasia passed away while waiting for a second lung transplant, leaving a legacy of courage and raising awareness about the challenges faced by CF patients.
